annual D&A:
$2.06M+$105.00K(+5.37%)Summary
- As of today (June 17, 2025), JANX annual depreciation & amortization is $2.06 million, with the most recent change of +$105.00 thousand (+5.37%) on December 31, 2024.
- During the last 3 years, JANX annual D&A has risen by +$1.95 million (+1723.01%).
- JANX annual D&A is now at all-time high.
Performance
JANX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$519.00K+$7000.00(+1.37%)Summary
- As of today (June 17, 2025), JANX quarterly depreciation & amortization is $519.00 thousand, with the most recent change of +$7000.00 (+1.37%) on March 31, 2025.
- Over the past year, JANX quarterly D&A has dropped by -$13.00 thousand (-2.44%).
- JANX quarterly D&A is now -2.44% below its all-time high of $532.00 thousand, reached on March 31, 2024.
Performance
JANX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.05M-$13.00K(-0.63%)Summary
- As of today (June 17, 2025), JANX TTM depreciation & amortization is $2.05 million, with the most recent change of -$13.00 thousand (-0.63%) on March 31, 2025.
- Over the past year, JANX TTM D&A has increased by +$13.00 thousand (+0.64%).
- JANX TTM D&A is now -1.54% below its all-time high of $2.08 million, reached on September 30, 2024.
Performance
JANX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
JANX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.4% | -2.4% | +0.6% |
| 3 y3 years | +1723.0% | +540.7% | +1006.5% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
JANX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1723.0% | -2.4% | +540.7% | -1.5% | +1006.5% |
| 5 y | 5-year | at high | >+9999.0% | -2.4% | >+9999.0% | -1.5% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -2.4% | >+9999.0% | -1.5% | >+9999.0% |
JANX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $519.00K(+1.4%) | $2.05M(-0.6%) |
| Dec 2024 | $2.06M(+5.4%) | $512.00K(+0.4%) | $2.06M(-0.9%) |
| Sep 2024 | - | $510.00K(+0.8%) | $2.08M(+0.5%) |
| Jun 2024 | - | $506.00K(-4.9%) | $2.07M(+1.7%) |
| Mar 2024 | - | $532.00K(+0.2%) | $2.03M(+4.0%) |
| Dec 2023 | $1.96M(+132.5%) | $531.00K(+6.2%) | $1.96M(+7.0%) |
| Sep 2023 | - | $500.00K(+6.2%) | $1.83M(+15.9%) |
| Jun 2023 | - | $471.00K(+4.0%) | $1.58M(+29.9%) |
| Mar 2023 | - | $453.00K(+12.4%) | $1.21M(+44.2%) |
| Dec 2022 | $841.00K | $403.00K(+61.8%) | $841.00K(+67.5%) |
| Sep 2022 | - | $249.00K(+130.6%) | $502.00K(+79.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $108.00K(+33.3%) | $280.00K(+51.4%) |
| Mar 2022 | - | $81.00K(+26.6%) | $185.00K(+63.7%) |
| Dec 2021 | $113.00K(+769.2%) | $64.00K(+137.0%) | $113.00K(+94.8%) |
| Sep 2021 | - | $27.00K(+107.7%) | $58.00K(+81.3%) |
| Jun 2021 | - | $13.00K(+44.4%) | $32.00K(+60.0%) |
| Mar 2021 | - | $9000.00(0.0%) | $20.00K(+53.8%) |
| Dec 2020 | $13.00K(+116.7%) | $9000.00(+800.0%) | $13.00K(+225.0%) |
| Sep 2020 | - | $1000.00(0.0%) | $4000.00(+33.3%) |
| Jun 2020 | - | $1000.00(-50.0%) | $3000.00(+50.0%) |
| Mar 2020 | - | $2000.00 | $2000.00 |
| Dec 2019 | $6000.00 | - | - |
FAQ
- What is Janux Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Janux Therapeutics?
- What is Janux Therapeutics annual D&A year-on-year change?
- What is Janux Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Janux Therapeutics?
- What is Janux Therapeutics quarterly D&A year-on-year change?
- What is Janux Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Janux Therapeutics?
- What is Janux Therapeutics TTM D&A year-on-year change?
What is Janux Therapeutics annual depreciation & amortization?
The current annual D&A of JANX is $2.06M
What is the all time high annual D&A for Janux Therapeutics?
Janux Therapeutics all-time high annual depreciation & amortization is $2.06M
What is Janux Therapeutics annual D&A year-on-year change?
Over the past year, JANX annual depreciation & amortization has changed by +$105.00K (+5.37%)
What is Janux Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of JANX is $519.00K
What is the all time high quarterly D&A for Janux Therapeutics?
Janux Therapeutics all-time high quarterly depreciation & amortization is $532.00K
What is Janux Therapeutics quarterly D&A year-on-year change?
Over the past year, JANX quarterly depreciation & amortization has changed by -$13.00K (-2.44%)
What is Janux Therapeutics TTM depreciation & amortization?
The current TTM D&A of JANX is $2.05M
What is the all time high TTM D&A for Janux Therapeutics?
Janux Therapeutics all-time high TTM depreciation & amortization is $2.08M
What is Janux Therapeutics TTM D&A year-on-year change?
Over the past year, JANX TTM depreciation & amortization has changed by +$13.00K (+0.64%)